288 related articles for article (PubMed ID: 22460460)
1. A new model of gastric bleeding induced in rats by aspirin plus clopidogrel under stimulation of acid secretion. Prophylactic effects of antiulcer drugs.
Takayama S; Izuhara C; Yamada N; Yamanaka S; Hashimoto E; Kaneko S; Takeuchi K
J Physiol Pharmacol; 2012 Feb; 63(1):41-52. PubMed ID: 22460460
[TBL] [Abstract][Full Text] [Related]
2. Effect of rebamipide on gastric bleeding and ulcerogenic responses induced by aspirin plus clopidogrel under stimulation of acid secretion in rats.
Takeuchi K; Takayama S; Hashimoto E; Itayama M; Amagase K; Izuhara C
J Gastroenterol Hepatol; 2014 Dec; 29 Suppl 4():37-46. PubMed ID: 25521732
[TBL] [Abstract][Full Text] [Related]
3. Animal models of gastric bleeding induced by dual antiplatelet therapy using aspirin and clopidogrel--prophylactic effect of antiulcer drugs.
Takeuchi K; Izuhara C; Takayama S; Momode T; Kojo M; Hara D; Amagase K
Curr Pharm Des; 2014; 20(7):1139-48. PubMed ID: 23782140
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of the anti-platelet drugs, clopidogrel, ticlopidine, and cilostazol on aspirin-induced gastric bleeding and damage in rats.
Takeuchi K; Takayama S; Izuhara C
Life Sci; 2014 Aug; 110(2):77-85. PubMed ID: 24984214
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic effect of egualen sodium, a stable azulene derivative, on gastrointestinal damage induced by ischemia/reperfusion, double antiplatelet therapy and loxoprofen in rats.
Amagase K; Yoshida Y; Hara D; Murakami T; Takeuchi K
J Physiol Pharmacol; 2013 Feb; 64(1):65-75. PubMed ID: 23568973
[TBL] [Abstract][Full Text] [Related]
6. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
Nishida A; Takinami Y; Yuki H; Kobayashi A; Akuzawa S; Kamato T; Ito H; Yamano M; Nagakura Y; Miyata K
J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of famotidine, omeprazole, and melatonin against acetylsalicylic acid-induced gastric damage in rats.
Sener-Muratoğlu G; Paskaloğlu K; Arbak S; Hürdağ C; Ayanoğlu-Dülger G
Dig Dis Sci; 2001 Feb; 46(2):318-30. PubMed ID: 11281181
[TBL] [Abstract][Full Text] [Related]
8. Role of nitric oxide in pathogenesis of aspirin-induced gastric mucosal damage in rats.
Takeuchi K; Yasuhiro T; Asada Y; Sugawa Y
Digestion; 1998; 59(4):298-307. PubMed ID: 9693199
[TBL] [Abstract][Full Text] [Related]
9. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
Amagase K; Kato S; Yamamoto H; Okabe S
Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
[TBL] [Abstract][Full Text] [Related]
10. Effects of the anti-ulcer agents ecabet sodium, cimetidine and sucralfate on acetylsalicylic acid-induced gastric mucosal damage deteriorated by renal failure in rats.
Nogi K; Taniguchi H; Onoda Y
Arzneimittelforschung; 2002; 52(11):828-32. PubMed ID: 12489254
[TBL] [Abstract][Full Text] [Related]
11. Lack of gastric toxicity of nitric oxide-releasing aspirin, NCX-4016, in the stomach of diabetic rats.
Tashima K; Fujita A; Umeda M; Takeuchi K
Life Sci; 2000 Aug; 67(13):1639-52. PubMed ID: 10983857
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of antiulcer activity of indole-3-carbinol and/or omeprazole on aspirin-induced gastric ulcer in rats.
El-Shinnawy NA; Abd-Elmageid SA; Alshailabi EM
Toxicol Ind Health; 2014 May; 30(4):357-75. PubMed ID: 22914261
[TBL] [Abstract][Full Text] [Related]
13. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
[TBL] [Abstract][Full Text] [Related]
14. Gastric antisecretory and anti-ulcer effect of ME3407, a new benzimidazole derivative, in rats.
Tanaka J; Iida H; Abe M; Yuda Y; Inoue S; Okabe S
Arzneimittelforschung; 2004; 54(4):221-9. PubMed ID: 15146935
[TBL] [Abstract][Full Text] [Related]
15. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
Sekiguchi H; Hamada K; Taga F; Nishino K
Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
[TBL] [Abstract][Full Text] [Related]
16. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic effect of lafutidine against the adverse reaction induced in rat stomach by repeated administration of 5-fluorouracil.
Kotani T; Nakagiri A; Murashima Y; Takeuchi K
Inflammopharmacology; 2007 Oct; 15(5):203-8. PubMed ID: 17943252
[TBL] [Abstract][Full Text] [Related]
18. Gastric antisecretory and antiulcer effects of simvastatin in rats.
Tariq M; Khan HA; Elfaki I; Arshaduddin M; Al Moutaery M; Al Rayes H; Al Swailam R
J Gastroenterol Hepatol; 2007 Dec; 22(12):2316-23. PubMed ID: 17593225
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological regulation of gastric acid secretion in the apical membrane of parietal cells; a new target for antisecretory drugs.
Okabe S; Shimosako K; Amagase K
J Physiol Pharmacol; 2001 Dec; 52(4 Pt 1):639-56. PubMed ID: 11787764
[TBL] [Abstract][Full Text] [Related]
20. Effects of the novel anti-ulcer agent 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine on experimental ulcers and gastric secretion in rats.
Tanaka T; Bickel M; Herling AW; Sakurai M; Goto M; Hayashi S
Arzneimittelforschung; 1989 Jun; 39(6):689-94. PubMed ID: 2775336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
